TLR4 and Arthritis: Wherein, the optimal AnCar‐ExoLaIMTS3 can efficiently deliver therapeutic contents to pro‐inflammatory macrophages mainly through TLR4‐mediated endocytosis, which ameliorates the severity of arthritis without obvious toxicity.